AEON / AEON Biopharma, Inc. - Net Long/Short Value

AEON Biopharma, Inc.
US ˙ NYSEAM

AEON / AEON Biopharma, Inc. - Net Long/Short Value
Auf dieser Seite finden Sie die Netto-Long/Short-Bewertungen für jede institutionelle Beteiligung, die über die 13F- oder NPORT-Berichte gemeldet wurde. Um den Netto-Long/Short-Wert zu berechnen, addieren wir den Aktienwert zum Wert der Call-Option und ziehen den Wert der Put-Option ab. Fonds, die geliehene Short-Positionen melden, weisen den Aktienwert als negativ aus. Netto-Long-Positionen haben positive Zahlen in der Netto-Long/Short-Spalte, und Netto-Short-Positionen haben negative Werte in dieser Spalte.
Besitzer Eigenkapitalwert
($1000)
Call Wert
($1000)
Put Wert
($1000)
Net Long/Short
($1000)
BlackRock, Inc.
Jane Street Group, Llc
LPL Financial LLC
SBI Securities Co., Ltd.
UBS Group AG
CIBC Private Wealth Group, LLC
Caitong International Asset Management Co., Ltd
Blue Owl Capital Holdings LP
Steward Partners Investment Advisory, Llc
Vanguard Fiduciary Trust Co
Morgan Stanley
Vanguard Group Inc
Wells Fargo & Company/mn
MAI Capital Management
Dupont Capital Management Corp
Formidable Asset Management, LLC
XTX Topco Ltd
Danske Bank A/s
Wolff Wiese Magana Llc
GHP Investment Advisors, Inc.
Geode Capital Management, Llc
Vanguard Global Advisers, LLC
Vanguard Capital Management Llc
Dauntless Investment Group, LLC
Citigroup Inc
Tower Research Capital LLC (TRC)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista